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Abstract
Measurement of carbon dioxide (CO2) in medical applications is a well-established
method for monitoring patient’s pulmonary function in a noninvasive way widely
used in emergency, intensive care, and during anaesthesia. Even in extra corpo-
real life support (ECLS) applications, such as Extra corporeal Carbon Dioxide Re-
moval (ECCO2R), Extra corporeal Membrane Oxygenation (ECMO), and cardiopul-
monary by-pass (CPB), measurement of the CO2 concentration in the membrane
oxygenator exhaust gas is proven to be useful to evaluate the treatment progress
as well as the performance of the membrane oxygenator. This thesis presents the
development of a new optical sensor specifically designed for the measurement of
CO2 concentration in the oxygenator exhaust gas. The project’s goal is to develop
a sensor with Technology Readiness Level of 9, meaning that the developed sen-
sor shall also be proven and validated in the operational environment. Initially, to
allow a better comprehension of the application for which the developed sensor is
intended, an overview of the ECLS application scenario is given, describing the key
components of an ECLS device, as well as the most used ECLS procedures. Fur-
ther, considerations about the importance of CO2 concentration measurement in the
membrane oxygenator exhaust gas are reported. Then, the measurement principle
for carbon dioxide concentration is described, as well as state-of-the-art technologies
used in this field. Moreover, design requirements that the developed sensor should
meet are analyzed and disclosed. Sensor architecture is described, focusing on the
method implemented to prevent condensation of the water vapour in the membrane
oxygenator’s exhaust gas. Effects of temperature on the performance of sensor’s
optical elements are addressed through theoretical and experimental analysis, and
methods to avoid signal–temperature dependency are described. Finally, the results
of the test performed on the developed sensor, both in-vitro and in-vivo conditions,
are reported and discussed.
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Capnometry is the measurement of carbon dioxide (CO2) concentration in respira-
tory gases [1]. It is a well-known and established method for monitoring patient’s
pulmonary function in a non-invasive way, widely used in emergencies, in intensive
care, or during anaesthesia [2, 3, 4, 5]. Even if the traditional use of capnometry is
related to the field of respiratory monitoring, the application of this measurement
in extra corporeal life support (ECLS) applications has been proposed. ECLS is
defined as a set of therapies that focus on oxygenation, carbon dioxide removal, car-
diac support, or a combination thereof [6]. Therefore, ECLS is used to treat those
patients with cardio-respiratory failure refractory to maximal conventional treat-
ment [7]. This support may facilitate therapeutic intervention, bridge to recovery,
bridge to a long-term support device, heart or lung transplantation, or bridge to
palliation. Recent research and development have transformed ECLS, which is now
being delivered at an increasing frequency to patients globally. The increasing dif-
fusion of ECLS is confirmed by the yearly report of Extra Corporeal Life Support
Organization (ELSO) [8], to which Figure 1.1 refers.
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Figure 1.1: The trend of ECLS Runs and ECLS Centers from 1990 to 2020.
As shown on Figure 1.1, over 30 years ECLS procedure runs per year has in-
creased from 1644 runs in 1990 to 15875 runs in 2020. Further, not only the number
of runs per year has increased, but also the number of centres equipped to perform
ECLS procedures (from 83 centres in 1990 to 463 of 2020).
Considering the increasing importance of ECLS as life-saving procedures, the
development of devices and sensors for ECLS application is becoming more critical.
Even though the use of capnometry in ECLS applications has been demonstrated
useful to improve safety and effectiveness of the extra corporeal procedure, it is
still not a routine measurement, primarily due to the lack of measuring systems
specifically designed for ECLS applications. From this consideration comes the
goal of this Industrial PhD, which is the development of a carbon dioxide sensor
specifically designed for ECLS applications. The developed sensor provides the
physicians and perfusionists information about CO2 clearance during the ECLS
procedure, which is useful to enhance both safety and effectiveness of the extra
corporeal procedure. Further, this PhD project’s goal is the development of a sensor
with Technology Readiness Level (TRL) of 9 [9], meaning that the developed sensor
shall also be proven and validated in the operational environment. To give a better
comprehension of the application in which the developed sensor is used, in this
chapter are disclosed the key components of an ECLS device and the most used
ECLS procedures. Finally, the importance of CO2 monitoring in ECLS application
is discussed.
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1.1 Key components of ECLS devices
In ECLS procedures, the functionality of the heart and lungs are temporally taken
over by external devices. In particular, the main components of an ECLS device
are:
• blood pump;
• extra corporeal oxygenator
1.1.1 Blood Pumps
In ECLS devices, a blood pump is used to substitute, partially or totally, the heart’s
functionality as the generator of the blood flow. In ECLS applications, two kinds of
blood pumps are used:
• roller pumps,
• centrifugal pumps.
Roller pumps, or peristaltic pumps, comprise a length of PVC or silicone tubing
situated against a curved metal backing plate (raceway) compressed by two rollers
located on the ends of rotating arms at 180° to each other. The direction of com-
pression of the tubing by the rotating arm containing the roller permits forward
blood flow. Hence, this type of pump is described as a positive displacement device,
allowing continuous delivery of blood volume despite variations in the outlet after-
load. In roller pumps, blood flow depends upon the pump tubing internal diameter,
rotation rate of the rollers and diameter of the pump head [10]. The following figure
shows the principle of operation of a roller pump.
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Figure 1.2: Schematic representation of a blood roller pump principle of operation.
Roller pumps are afterload independent, meaning that the increase of resistance
downstream the pump does not affect the blood flow generation. Therefore, flow
generation depends only on revolution per minutes (RPM) of the pump head, allow-
ing simple monitoring of the pump functionality. Nevertheless, monitoring pressure
downstream the pump is necessary to avoid circuit breakage due to the excessive
pressure generated by the pump in case of tube occlusion. Further, roller pumps
are defined as occlusive pumps since the constant presence of a roller that pushes
on the tube wall prevents backflow in case of pump stop. Finally, roller pumps
are versatile since they allow to change the flow direction if needed, changing the
rotation sense of the pump head [11]. The main disadvantage of roller pumps is
represented by blood damage due to high shear rates induced in the rollers’ vicinity
during occlusion, particularly during the reopening of the tubing once the roller
has passed. During reopening, there may be momentary backflows with very high
velocities. High shear on the cell membranes can lead to premature ageing of the
red blood cells, which leads to clumping, and in extreme cases, to hemolysis of the
red blood cells, releasing haemoglobin into the plasma [12]. However, roller pumps
are still used, especially in short-term ECLS procedures such as cardiopulmonary
by-pass (CPB).
Centrifugal pumps generate blood flow through the "vortex" effect. Within a
plastic case (pumping chamber) a rotating body (impeller) generates a low-pressure
zone at the centre of the pumping chamber, in which the blood is withdrawn, and a
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high-pressure zone at the peripheral of the pumping chamber, from which the blood
is ejected.
Figure 1.3 shows the principle of operation of a centrifugal pump.
Figure 1.3: Schematic representation of a blood centrifugal pump principle of operation.
Generated blood flow depends on RPM of the rotating body and pressure drop
across the pump. Therefore, unlike roller pumps, a variation of the resistance down-
stream the pump leads to significant variation of the generated blood flow. There-
fore, due to dependency on the afterload, a direct measuring of the blood flow
downstream the centrifugal pump to assure correct perfusion of the patient is neces-
sary. An ultrasonic flow sensor is often used for this purpose. Centrifugal pumps are
defined as non-occlusive pumps, since blood can pour in both directions, according
to the pressure gradient, if the pump is stopped. The main advantage of centrifugal
pumps compared to roller pumps is the lower hemolysis produced by the pump ac-
tion. Centrifugal pump action is less traumatic for blood cells since there is no direct
friction of the impeller with the pump housing, and free blood paths are present.
However, the presence of turbulence or stagnation area within the pump may lead
to high shear stress, hemolysis or thrombus formation. Impeller used in centrifugal
blood pumps contains a magnet at the base. This magnet is used to couple the
impeller to an electrical motor that generates the rotation force. Depending on the
method used to generate the impeller rotation, centrifugal pumps can be divided in:
• magnetic rotation centrifugal pump and,
• magnetic levitation centrifugal pump.
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Magnetic rotation centrifugal pumps are composed of a magnetic impeller cou-
pled with a magnet placed on an external rotor. Rotation of the rotor element leads
to rotation of the impeller within the pumping chamber. In order to maintain the
impeller at the centre of the pumping chamber and avoid friction with the pump
housing, shaft and bearings are necessary (Figure 1.4). However, the presence of
shaft and bearings within the pump housing represents a discontinuity in the blood
path, leading to turbulence and stagnation, thus increasing the risk of hemolysis
and thrombus formation. Despite the presence of turbulence and stagnation area,
magnetic rotation centrifugal pumps are anyway characterized by lower hemolysis
rate than roller pumps [13].
Figure 1.4: Schematic representation of a magnetic rotation centrifugal pump.
In magnetic levitation centrifugal pumps, the impeller’s positioning and rotation
are achieved through electromagnetic coupling of a magnet within the impeller and
a magnetic field generated by electrical currents flowing in windings placed on an
external stator. Since the impeller within the pumping chamber levitates and is
maintained in a central position by the generated magnetic field, there is no need
of shaft or bearings, and therefore within the pumping chamber, there is no discon-
tinuity on the blood paths. (Figure 1.5) . Magnetic levitation centrifugal pumps
represent the best solution in terms of hemolysis rate.
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Figure 1.5: Schematic representation of a magnetic levitation centrifugal pump
1.1.2 Extra corporeal Oxygenator
To temporally substitute the lungs’ functionality, an extra corporeal oxygenator, also
known as artificial lung, is used in ECLS procedures. As a substitute of the patient’s
lungs, an oxygenator’s purpose is to replace the organ gas exchange function during
extra corporeal circulation, assuring both blood oxygenation and carbon dioxide
removal [14]. There are different possibilities for blood-gas interaction: blood can
be fed to a gaseous phase as in film oxygenator (obsolete in clinical practice), gas
can be added to blood as in bubble oxygenator (rarely used anymore), or blood and
gas can be separated by a membrane (nowadays membrane oxygenator).
In membrane oxygenator (MO), blood and gas compartments are divided by a
membrane that is permeable to gas transfer. [15]. Venous blood enters the oxygena-
tor, while gas (sweep gas) is also provided to the MO. Inside the MO gas exchange
occurs, O2 is added to blood while CO2 is removed. Oxygenated blood then exits
the MO returning to the patient’s, while removed carbon dioxide is released in the
atmosphere as exhaust gas. Therefore, in MO are present four connectors: blood
inlet, blood outlet, gas inlet and gas outlet. In order to improve gas exchange, blood
and sweep gas flows in a perpendicular direction. The membrane of modern MO can
be divided into two categories: diffusion membrane (made of silicone) and microp-
orous membrane. The second category is the most used nowadays. While diffusion
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membrane is made of semi-permeable material that allows only the gas to move
to the blood compartment and not the contrary, microporous membrane consists of
hollow fibres with 0.05–0.3 µm pores that initially create a direct blood gas interface
until a thin protein film quickly forms, producing molecular membranes. The gas
exchange occurs by diffusion of the gases across microporous fibre surface, oxygen
moving from the interior of the hollow fibre into the blood and carbon dioxide dif-
fusing from the blood cross into the interior of the fibre and swept away by the gas
flow through the hollow fibre [16]. Since the membrane surface is hydrophobic and
the pores are small, no ultrafiltration of water occurs and gas and serum remain
separated. Figure 1.6 shows the layout of a membrane oxygenator and its working
principle.
Figure 1.6: a)Microporous membrane oxygenator. b)Working principle schematic of a
microporous membrane oxygenator.






where: Vgas [ml/min] is the gas flow across the membrane; A [m2] is the membrane
area; D [m2/s] is the diffusion constant (that depends on the gas molecule of in-
trest) δP [mmHg] is the partial pressure difference (that represent the concentration
gradient) across the membrane; ad T [m] is the membrane thickness. Equation 1.1
15
highlights that to increase gas transfer efficiency, blood-gas contact area shall be as
larger as possible. Microporous membrane oxygenators are composed by a bundle
of porous hollow fibres made of polypropylene or polymemethylpentene (PMP) and
offer a more extensive exchange area than silicone membrane oxygenator. Neverthe-
less, is important to highlight that in membrane oxygenator the exchange surface
area is 1.7-3.5 m2 compared with 70-100 m2 of natural lungs, while diffusion distance
in MO is around 200 µm compared to the 10 µm of the human alveolus. Therefore,
artificial lungs can not wholly substitute natural lungs in terms of gas exchange
performance. The gas transfer also depends on the diffusion gradient across the
membrane. Considering that the gas provided to the oxygenator is saturated with
oxygen, for O2 the partial pressure difference is 760 mmHg minus the O2 tension of
venous blood, while for CO2 is equal to the carbon dioxide tension in venous blood.
Despite the pressure gradient for O2 is higher than the pressure gradient for CO2,
the material of the membrane oxygenator is more permeable to CO2 than O2 [17].
Even though the membrane of MO is made of a hydrophobic material, over time,
adsorption of plasma proteins creates a hydrophilic passage on the micropores of the
membrane. This leads to movement of liquid through the micropores from the blood
to the gas side of the membrane, this phenomenon is called plasma leakage [18]. In
practice, plasma leakage results in deterioration of gas exchange and gross leakage
of plasma [19]. PMP membrane oxygenators are characterized by significantly less
plasma leakage and a longer functional lifetime, up to several weeks [20]. Reduction
of gas exchange capability may also result from clot formation on the membrane,
which decreases the available surface area for gas exchange, and excess condensa-
tion in the membrane lung ("pulmonary oedema") [21]. The causes mentioned above
may lead to MO failure and, therefore its replacement.
1.2 ECLS procedures
Even though all ECLS procedures involve blood pumps and membrane oxygenators,
several different ECLS procedures exist, which differs for therapeutic goal, duration
and kind of support provided to the patient. In this section, the below listed ECLS
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procedure are described:
• Cardiopulmonary by-pass (CPB)
• Extra corporeal Membrane Oxygenation (ECMO)
• Extra corporeal CO2 Removal (ECCO2R)
1.2.1 Cardiopulmonary by-pass - CPB
Cardiopulmonary by-pass, or CPB, is a form of extra corporeal circulation that
redirects the patient’s blood from venae cavae directly to the aorta, therefore by-
passing both heart and lungs. The CPB procedure’s goal is to provide a bloodless
field to cardiac surgery, necessary for "open heart" surgical operations. During the
surgical operation, the heartbeat is stopped, CPB circuit allows both circulatory
and respiratory support along with temperature management [22]. CPB procedure
is managed through a device called Heart-Lung Machine (HLM), which is composed
of both disposable components and hardware and electronic devices. The main





• Cardiotomy Suction System
Figure 1.7 shows the schematic of a cardiopulmonary by-pass system [23].
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Figure 1.7: Schematic of a cardiopulmonary by-pass system
Patient’s venous blood is collected in the venous reservoir that serves as a mixing
chamber for all blood returning (e.g. cardiotomy and cardioplegia circulation). Fur-
ther, the venous reservoir is filled by gravity. Therefore, it is usually placed below
the patient’s level; in this way, the patient is decoupled from the systemic pump, pre-
venting excessive suction. The systemic pump acts as an artificial heart by pulling
the blood from the venous reservoir and directing it towards the membrane oxygena-
tor and then back to the patients through the aorta [24]. Both centrifugal and roller
pumps are used as systemic pump. Roller pumps, even though more hemolytic, re-
sults suitable due to the "short-term" nature of the CPB procedure since the surgical
procedure’s duration is in the order of hours. In the membrane oxygenator, venous
blood is oxygenated, and carbon dioxide is removed, obtaining arterial blood that
is returned to the patient. Cardioplegia system can be considered as an additional
circulation line, in which blood is withdrawn from the extra corporeal circuit (e.g.
from the venous reservoir) and mixed with cardioplegia solution. Cardioplegia solu-
tion is a pharmaceutical solution that stops the heartbeat when mixed with blood
and provided to the myocardium. Usually, potassium-based cardioplegia solution
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is used, since allows the heart to stop during the diastole phase, meaning that the
heart tissue is relaxed and therefore easier to manage during the surgical procedure
[25]. Considering the small amount of blood volume processed by the cardioplegia
system, roller pumps are commonly used for this purpose. Cardiotomy suction sys-
tem is composed of roller pumps that withdraw the blood from thoracic cavity and
blood that is returned directly to the heart (e.g. through the Tebesio veins), and
return it to the venous reservoir. The cardiotomy suction system allows to obtain a
bloodless surgical field and not waste blood produced by surgical operations. How-
ever, cardiotomy suction blood contains fat, bone, lipids, and other debris from the
surgical field. This blood is also exposed to air, shear forces, and artificial surfaces
that cause exacerbation of the systemic inflammatory response and result in micro-
circulatory dysfunction. These substances are dangerous if delivered to the patient;
therefore cardiotomy suction blood is treated through dedicated filters [26].
1.2.2 Extra corporeal Membrane Oxygenation - ECMO
Extra corporeal membrane oxygenation, or ECMO, is used for the management
of life threatening pulmonary or cardiac failure (or both), when no other form of
treatment has been or is likely to be successful. It is used as temporary support,
usually awaiting recovery of organs. ECMO is essentially a modification of the
cardiopulmonary by-pass circuit which is used routinely in cardiac surgery. Blood is
removed from the venous system either peripherally via cannulation of a femoral vein
or centrally via cannulation of the right atrium, oxygenated, has its carbon dioxide
extracted and then returned back to the body, either peripherally via a femoral
artery or centrally via the ascending aorta [27]. Unlike CPB, native lungs and
heart are not entirely excluded from the circulation, but instead, the artificial heart
(pump) and lungs support the native organs during their recovery. The primary
ECMO circuit consists of a blood pump, the membrane oxygenator, conduit tubing,
a heat exchanger, and drainage and return cannulae. The circuit drains blood
from the venous system and pumps it through a membrane oxygenator where O2 is
added, and CO2 is removed, returning newly oxygenated blood to the patient [28].
Depending on the cannulation configuration used, ECMO can provide circulatory
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and respiratory support or only respiratory support. Venoarterial ECMO (VA-
ECMO) is able to provide both respiratory and circulatory support. Deoxygenated
blood is drained from the venous system, and oxygenated blood is returned into
the arterial circulation, in a similar fashion to standard cardiopulmonary by-pass.
The pulmonary circulation is by-passed by placing the artificial lung in parallel
with the native lungs [29]. Venovenous ECMO (VV-ECMO) is intended to provide
partial or complete respiratory support without any cardiac support, so VV-ECMO
is indicated only when native cardiac output is sufficient. VV-ECMO places the
native lungs in series with the artificial lung. In adults, several cannulation options
currently exist. Traditionally, deoxygenated blood is drained from a femoral vein
and returned to the right internal jugular vein [30]. More recently, a bicaval dual-
lumen catheter has been developed to provide both drainage and return directly
into the right atrium via the internal jugular vein [31]. In the following figure, a
schematic representation of VA-ECMO and VV-ECMO is reported.
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Figure 1.8: Schematic representation of VA-ECMO and VV-ECMO configurations.
In the recent period, due to Covid-19 pandemic, there has been a steady increase
in ECMO use [32]. Since covid-19 patients may be affected by acute respiratory dis-
tress syndrome (ARDS) refractory to mechanical ventilation and traditional strate-
gies, ECMO represents an alternative method to cure these patients assuring blood
oxygenation [33, 34]. At the time of writing this thesis, there were 3684 patients
treated with ECMO [35].
1.2.3 Extra corporeal CO2 Removal - ECCO2R
Extra corporeal carbon dioxide removal (ECCO2R) is a technique that provides
artificial respiratory support removing CO2 from the blood through a membrane
oxygenator [36]. ECCO2R devices include a drainage cannula placed in a central
vein (VV configuration) or artery (AV configuration), an artificial lung, and a return
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cannula into the venous system [37].
Figure 1.9: Schematic representation of VA-ECCO2R and VV-ECCO2R configurations.
Application of high sweep fresh gas flow generates a diffusion gradient which
allows CO2 removal [38]. Moreover, CO2 removal rate depends on the blood flow to
the membrane: 1 L of blood contains around 500 mL of CO2 or more and the CO2
production per minute is about 200–250 mL/min; thus a blood flow of 0.5 L/min
would be sufficient to remove all of the CO2 produced by the body [39]. Therefore,
meaningful CO2 removal rate can be obtained with a blood flow of 300-1000 ml/min.
Although it has been reported that a blood flow of 300–500 mL/min potentially re-
places about 50% or more of the exchange function of the native lung [39, 40],
the percentage is very often lower, as it depends on the actual blood CO2 content,
haemoglobin concentration and the exchange performance of the membrane. There-
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fore, ECCO2R may typically remove about 25% of total CO2 production [39, 40]
Since ECCO2R is a low blood flow procedure, roller pumps can be used even though
this kind of procedure can last for days [41]. Further, as reported in Figure 1.9, AV
configuration, is pumpless. Considering the low blood volume involved, blood is
pushed through the oxygenator by patient’s arterial pressure in this configuration.
ECCO2R is applied to treat hypercapnia condition, that is a condition of abnor-
mally elevated carbon dioxide levels in the blood. Hypercapnia can be generated
by pathophysiological changes in the respiratory system or from specific mechanical
ventilation protective strategies [42]. Hypercapnia negatively affects several extra-
pulmonary organs, in particular brain and cardiovascular system. By increasing
cerebral blood flow, hypercapnia elevates intracranial pressure [42, 43]. Hypercap-
nic acidosis increases pulmonary vasoconstriction and, in addition to microvascular
alterations and the effects of positive-pressure MV dramatically increases right ven-
tricular (RV) afterload [44]. At the same time, hypercapnia and hypercapnic acido-
sis decrease myocardial contractility. This altered hemodynamic profile contributes
to RV-arterial decoupling and acute RV dysfunction [42, 44]. ECCO2R is used to
treat ARDS patients and treat severe asthma, chronic obstructive pulmonary disease
(COPD) and as bridge to transplantation strategy. ARDS patients are commonly
treated with invasive mechanical ventilation. However, mechanical ventilation car-
ries the risk of ventilator-induced lung injury (VILI), due to inhomogeneous lung
overdistention. In order to reduce VILI occurrence, driving parameters of the me-
chanical ventilator can be reduced (protective ventilation). However, this strategy
may lead to hypercapnia condition. ECCO2R can be used to remove the excess
of CO2 from patient’s blood, and allow protective ventilation, thus reducing VILI.
Further, the use of ECCO2R has been associated with facilitation of weaning from
invasive mechanical ventilation (IMV), and also with support to non-invasive ven-
tilation (NIV), avoiding intubation of the patient. Finally, since ECCO2R prevents
the use of IMV in favour of NIV, it can be considered a bridge to lung transplant
procedure, since it limits the adverse effect of IMV that can preclude lung trans-
plantation.
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1.3 Oxygenator exhaust capnometry
All the ECLS procedures mentioned in the previous sections represent complex
systems that require strict monitoring of both patient and device conditions. As
previously mentioned, all ECLS procedure involves a membrane oxygenator, that is
responsible for blood oxygenation and carbon dioxide removal from patient’s blood.
Removed carbon dioxide is released in the environment as exhaust gas, through the
gas outlet connector of the MO. Therefore, the measurement of CO2 removed by
the MO can be achieved by placing a CO2 sensor (also called capnometer) at the
MO exhaust port. This method is called "oxygenator exhaust capnometry". In this
section, the importance of CO2 concentration measurement in the oxygenator ex-
haust gas is disclosed. CO2 removal monitoring during cardiopulmonary by-pass is
considered a recommended guideline for practice by the American Society of Extra
Corporeal Technology [45]. Carbon dioxide tension (PCO2) measured by exhaust
oxygenator capnometry is representative of the interaction of CO2 production and
its elimination by the artificial lung. Therefore, this measurement can provide im-
portant information related to both efficacies of CO2 removal and metabolic status
of the peripheral organs and the adequacy of their perfusion [46]. From the measure-
ment of CO2 concentration of exhaust gas is possible to obtain the carbon dioxide
removal rate through the following equation:
V CO2(ml/min) =
GF (ml/min) · ePCO2(mmHg)
760(mmHg)
(1.2)
where: VCO2 is the CO2 removal rate expressed in mL/min, ePCO2 is the carbon
dioxide concentration in the exhaust gas expressed in mmHg and GF is the sweep gas
flow provided to the oxygenator expressed in mL/min. During CPB, an alternative
method to estimate VCO2 is based on Fick’s principle, and does not require knowing
the ePCO2 value:
V CO2 = Qc · (mixed venous CO2 content - arterial CO2 content) (1.3)
Venous and arterial CO2 content can be acquired by blood gas analysis or in-line
blood parameters monitoring devices. However, even though Fick’s law is accurate
for determination of VO2, for carbon dioxide is less precise, since CO2 in the blood
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is carried by different ways: dissolved (about 10 %), in form of bicarbonate (about
10 %) and associated with proteins ( about 10 %) [47]. Experimental studies have
demonstrated that VCO2 value obtained through exhaust oxygenator capnometry
(Equation 1.2) is more reliable than VCO2 obtained through blood gas analysis
(Equation 1.3) [48, 49]. Even though in-line blood monitoring systems (e.g. Terumo
CDI 500) have been demonstrated to be reliable in measuring PCO2 value [50], they
present several disadvantages when compared to gas-phase monitoring methods such
as oxygenator exhaust capnometry [51]. First, in-line blood measurement has lower
long-term stability, and calibration with a gas sample is always required before use
to not affect measurement accuracy. Further, since the in-line blood measurement
exploits fluorescence, dedicated disposable microsensors are needed, increasing the
complexity and cost of the disposable circuit, which are also characterized by lower
durability. Finally, while gas-phase measurements are non-invasive, in-line blood
measuring systems involve blood contact and by-pass line, with the consequent risk
of blood coagulation and air infusion.
Oxygenator exhaust capnometry can be used to estimate arterial carbon dioxide
tension (PaCO2) during CPB. Several works have demonstrated a good correlation
between ePCO2 and PaCO2 during CPB procedures [52, 53, 54]. Further, VCO2 is
considered a good predictor of anaerobic metabolism during CPB that leads to an
increased CO2 production by the patient’s metabolism [55], and also its monitoring is
important to prevent postoperative renal insufficiency[49, 56]. Finally, since during
CPB CO2 is provided to the patient to facilitate the air removal from cardiac cavities
and improve neurological outcome, a massive quantity of carbon dioxide will enter
the systemic circulation hypercapnia condition. Oxygenator exhaust capnometry
can be used to monitor the non-metabolic CO2 and allow its removal increasing
the sweep gas flow [49]. Monitoring of CO2 in the oxygenator exhaust gas is also
important to evaluate the membrane oxygenator’s performance. Since MO failure
is the second most common mechanical complication during ECLS, its monitoring
is crucial in order to recognise the right timing for ML replacement [29]. Causes
of MO failure include either fibrin clot formation or water condensation, both of
which diminish the membrane’s ability to transfer oxygen and CO2. An incidence
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of oxygenator failure or clot in the oxygenator is reported in 21.6% of respiratory
ECMO runs in the neonatal and pediatric population [57]. Continuous monitoring
of CO2 concentration in the oxygenator exhaust allows calculation of the so-called
"membrane oxygenator dead space" (VDsMO), that represent the number of fibres
within the oxygenator that are ventilated but not perfused due to clot formation or
water condensation on fibres, and therefore does not participate to gas exchange [58].
Considering the parallelism between the artificial lung and natural lungs, VDsMO





· V T (1.4)
where: VD is the respiratory dead space, PaCO2 is the partial pressure of carbon
dioxide in the arterial blood [mmHg] and PeCO2 is the partial pressure of carbon
dioxide in the expired air [mmHg]. Similarly, for the membrane oxygenator, the





where: VDsMO[%] is the MO dead space expressed as percentage, PCO2out is
the carbon dioxide in the blood downstream the oxygenator [mmHg] and ePCO2
is the carbon dioxide concentration measured in the oxygenator exhaust [mmHg].
PCO2out can be obtained through BGA or in-line blood monitoring device. In
case of MO failure, ePCO2 will drop while PCO2out will increase , leading to an
higher VDsMO meaning that the gas exchange is impaired. On the other hand,
if the CO2 produced by the patient metabolism decreases, the difference between
PCO2out and ePCO2 will remain constant. Therefore, it is possible discriminate
between ePCO2 reduction due to MO failure or ePCO2 reduction due to change
in patient’s conditions. This kind of monitoring of the VDsMO allows to promptly
detect the decrease in MO performance, and eventually prepare the MO substitution
in advance.
During ECMO procedure, monitoring MO performance may provide informa-
tion regarding both the patient’s lung status and the MO contribution to the global
ventilation, therefore guiding the weaning process [59]. In ECCO2R, the measure-
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ment of CO2 concentration in the exhaust gas and of CO2 removal rate represents
a key parameter to estimate the treatment progress, and evaluate the performance
of ECCO2R membrane in terms of CO2 clearance.
In conclusion, oxygenator exhaust capnometry can be considered a useful tool
for monitoring both the patient’s status during the ECLS procedure and allowing
correct management of the procedure and improving its safety, assuring a better
patient outcome.
Despite its relative ease, oxygenator exhaust capnometry is not routinely ap-
plied, as some practical issues remain unsolved in providing a reliable measurement
of CO2 removal from the patient. Usually, oxygenator exhaust capnometry is per-
formed using CO2 sensors intended for respiratory monitoring, placing the sensor at
the gas outlet connector of the MO once per day [58], and obtaining the relevant
information from the CO2 concentration value. However, this kind of measurement
does not allow to fully exploit the oxygenator exhaust capnometry potential. Only
two devices intended for oxygenator exhaust capnometry are available on the mar-
ket, the Hemolung RAS (A-Lung Technologies, Inc.) that is a device for ECCO2R
procedure with a built-in CO2 sensor that allows measurement of extracted CO2,
and System M4 (Spectrum Medical Ltd.) a multi-parameter monitoring system in-
tended for ECLS procedures. In the next chapter, CO2 measuring principle and
state of the art of CO2 sensors are disclosed, as well as the requirements that a CO2




In this section, the measuring principle used for measurement of CO2 is described, as
well as methods to implement it. State-of-the-art sensor architecture used in carbon
dioxide measurement in medical applications are also disclosed. Finally, an analysis
of the requirements that should be met in the design of a CO2 sensor intended for
ECLS application is reported.
2.1 CO2 concentration measuring principle
Even though there are several methods that can be used for CO2 measurement,
based for example on chemical or photoacustic principles, optical-based sensors
represent the state-of-the-art in the measurement of CO2 concentration in gases
[60]. The potential of optical methods of gas analysis exceeds that of electrochem-
ical and catalytic methods, ensuring high speed, selectivity, stability to aggressive
media and long service life. These are typically based on infrared spectroscopy,
a well-known technique that exploits molecules’ ability to absorb light at specific
wavelengths related to vibration and rotation mechanisms of molecules [61]. The
Bourger–Lambert–Beer Law describes the working principle of these sensors [62]:
dI = −α(λ)cIodx (2.1)
where I is the transmitted radiation intensity, Io is the incident radiation intensity, c
is the analyte concentration, α(λ) is the analyte-specific absorption coefficient, and x
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shows that it is possible to calculate the analyte concentration observing variation
of the transmitted radiation I [arbitrary unit], as it represents attenuation of the
incident radiation Io [arbitrary unit] once it has passed through the optical path x
[cm] containing an amount c [mol/l] of the analyte with absorption coefficient α(λ)
[l · mol−1 · cm −1]. In Equation 2.2 is highlighted that the absorption coefficient is
a wavelength-dependent parameter, so to correctly exploit the absorption measure-
ment principle is of paramount importance that the incident light has a spectrum
that includes the absorption band of the analyte of interest. For CO2, the incident
light spectrum shall be in the mid-infrared (mid-IR) region (3 - 8 µm) as the prin-
cipal absorption peak for carbon dioxide is located at 4.25 µm [63]. Further, to
obtain a direct measurement of the analyte of interest and avoid cross-response to
other chemical species, no other compounds shall have absorption bands included
on the incident light spectrum. Therefore, the whole composition of the oxygenator
exhaust gas mixture must be considered to develop an efficient CO2 sensor for ECLS
applications. The exhaust gas of a membrane oxygenator during ECLS procedure
contains a variable concentration of the following chemical species: Oxygen (O2),
Nitrogen (N2), Carbon Dioxide (CO2), and water vapour. As infrared radiations
are absorbed only by asymmetrical molecules, only CO2 and water vapour (H2O)
have absorption bands in the mid-IR region. Absorption spectra of CO2 and H2O
obtained from the HITRAN database [64] are reported in Figure 2.1.
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Figure 2.1: Absorption bands of CO2 (orange) and H2O (blue).
Method to obtain emission in the mid-IR spectrum used in the currently available
capnometers are based on Nondispersive infrared (NDIR) technology since no dis-
persive elements (e.g. prism) are used to separate the emitted broadband radiation
into narrow spectrum suitable for analyte sensing. Typically, the emitted radiation
is generated by a broadband emitting incandescence light source. The spectral emis-
sion characteristic of an incandescent light source can nearly be described by the
Planck’s law for black body radiation. The emitted light intensity and the spectral
distribution is only depending on the surface temperature of the emitter element
[65]. To prevent cross-response from compounds other than the one of interest, the
broadband emission spectra generated by the incandescent light source is filtered by
optical bandpass filters. Coupling a broadband emitting incandescence light source
with at least two optical filters, one for the analyte of interest absorption and one
for reference, a differential measurement can be made and interfering broadband
absorption is prevented. Different optical set-ups are implemented in CO2 sensors
used in capnometry:
• Emission light spectrum is generated through an incandescent filament. The
broadband spectrum is directed to a single IR detector. The emitted light is
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filtered and modulated by a rotating wheel placed in the optical path [66].
• The emitted light is directed through the measuring chamber to a spectrally
separating beam splitter that directs the light towards two differents IR de-
tectors [67, 65].
• The emitted IR radiation reaches two different detectors that have a specific
IR bandpass through different optical paths [68].
Usually, detector elements are thermophiles or pyroelectric detectors.
An alternative optical set-up for CO2 measurement in gas consists of the use of
a narrow spectrum emitting diode coupled with an appropriate photodetector. This
solution is possible thanks to the use of light-emitting diode (LED) and photode-
tector (PD) realized with Indium (In), Arsenic (As), Antimony (Sb) epitaxial layer
on Indium (In) Arsenic (As) substrate (InAsSb/InAs optical element) [69]. Using
appropriate mid-IR LED and PD an optopair, i.e., a source and detector elements
that are optically and spectrally matched, CO2 measurement can be made. Opti-
cal coupling of InAsSb/InAs LED and PD allows the emission and detection of IR
radiation near 4.2 µm that comprises the principal CO2 absorption peak. Further,
the narrow emission and detection spectra that characterize InAsSB/InAs optical
elements allow the direct measurement of CO2 even in the presence of water vapour,
as reported in Figure 2.2.
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Figure 2.2: InAsSb/InAs LED (green) and PD (purple) spectra. Absorption bands of
CO2 (orange) and H2O (blue).
Therefore, an optical set-up that involves InAsSb/InAS optopair allows the de-
sign of an optical sensor without using mechanical modulators or interference filters,
thus allowing a simpler optical design of the sensor, involving fewer components. In
the following figure is reported the schematic of a single channel architecture, mean-
ing that the optopairs is made up by a single LED and a single PD.
Figure 2.3: Schematic representation of a single channel optopair architecture
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2.2 State-of-the-art CO2 sensor architectures
In commercially available capnometers for respiratory monitoring, two different sen-
sor’s architectures are used for measurement of CO2 concentration [70]:
• non-diverting (Main-stream);
• diverting (Side-stream).
In non-diverting, or Main-stream, capnometers architecture, the optical absorp-
tion measurement is taken in-line with the respiratory stream, through a measuring
cuvette transparent to the mid-IR radiation. The acquired data are then sent from
the optical sensor probe to a display unit. In Side-stream architecture, a portion
of the gas is pulled from the respiratory stream flow into the absorption chamber,
that is spatially separated from the main respiratory flow. The optical sensor is con-
tained within the control unit that display the CO2 concentration value [65, 71, 72].
Figure 2.4 shows a schematic representation of Main-stream and Side-stream sensors
architecture.
Figure 2.4: Main-stream and Side-stream capnometry architecture
In main-stream capnometers, the measuring cuvette shall be designed to allow
the mid-IR beam generated by the emitter source to reach the detector crossing the
gas to be measured. In order to achieve transparency to mid-IR beam, cuvette used
in main-stream capnometry are designed with two optical windows, typically made
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of sapphire glass. Exhaled breath contains water vapour, that is able to absorb
mid-IR radiation. However, CO2 absorption band at 4.25 µm is relatively free
water vapour interference. However, water vapour may represent a problem since
it can condensate on the optical windows and lead to incorrect CO2 concentration
readings. This effect has been effectively minimized in main-stream systems by
heating the airway adapter, and its windows above body temperature [71]. In side-
stream systems, the sampled gas temperature decreases toward room temperature
during its transit from the patient connection to the sensor unit [73]. Consequently,
condensation on the sampling tube walls happens, resulting in a decrease in the
partial pressure of water vapour from the Body Temperature and Pressure Saturated
condition (BTPS) value of 47 mm Hg to much lower values. This decrease in water
vapour pressure can cause an apparent increase in CO2 concentration [74]. Side-
stream devices compensate by software water vapour removal, and as a result, may
introduce errors since assumed conditions may be very different from actual, and
physical conditions may change over time. Main-stream CO2 correctly read the
partial pressure of CO2 at the conditions in the breathing circuit typically at or near
BTPS and do not require software compensation for water vapour [71]. Further, in
side-stream sensor water vapour condensation or water-like substances (generated
by patient’s secretions) may lead to partial obstruction of the sampling line and,
therefore, increase the tube’s resistance, affecting the CO2 measurement. In the
most severe cases, the sampling tube may be totally occluded, preventing the gas
from reaching the sensor unit.
2.3 Design Requirements analysis for ECLS CO2
sensor development
In this section, the requirements that should be met in the design of a CO2 sensor




• water vapour condensation
• sensor architecture
• gas flow measurement
• interface to other devices
Since there are no standards that specify the minimum accuracy level for a
CO2 sensor intended for ECLS application, the "closest" applicable standard is ISO
80601-2-55 - Medical electrical equipment — Part 2-55: Particular requirements
for the basic safety and essential performance of respiratory gas monitors, that
specifies particular requirements for the basic safety and essential performance of
a respiratory gas monitor. Clause 201.12.1.101 of the ISO 80601-2-55 specifies the
minimum accuracy level for different gas concentration measurement. For carbon
dioxide, minimum accuracy level specified by the standard is [75]:
CO2 Measurement Accuracy = ±0, 43% + 8% GAS LEV EL (2.3)
where GAS LEVEL is the gas concentration expressed in volume percentage. How-
ever, CO2 sensors used for respiratory monitoring, shown better accuracy perfor-
mance than the one reported in the standard. For example, Medtronic Microstream
CO2 sensor, used in side-stream capnometers, has an accuracy of ± 2mmHg for
carbon dioxide concentration between 0-38 mmHg, and ± 5% of reading + 0.08 for
every 1 mmHg above 38 mmHg [76]. An mmHg is equal to a concentration 0,13%
in volume percentage. Respironics Capnostat 5, is a main-stream capnometer and
show the following accuracy performance: ± 2mmHg in the range 0-40 mmHg, ±
5% of reading in the range 41-70 mmHg, ± 8% of reading in the range 71-100 mmHg
and ± 10% of reading in the range 101-150 mmHg [77]. A CO2 sensor designed for
ECLS application should have similar accuracy performance, or at least within the
accuracy limits specified by the ISO 80601-2-55 standard.
A second aspect to take into account is that in ECLS procedures water vapour
condensation at the exhaust port of the MO occurs. Due to the microporous nature
of the membrane, blood plasma can evaporate at the liquid-membrane interface and
diffuse as water vapour across the pores into the fibres’ intraluminal space, in which
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sweep gas flows. Water vapour condensation at oxygenator gas outlet connector is
associated with the sudden cooling of the gas flow in the proximity of the outlet
cover, where the warming effect of blood is no longer present. Since condensation
within the fibres of the membrane oxygenator can reduce the gas transfer efficiency,
several methods have been proposed to prevent the condensation effect, such as
warming the gas at the inflow or outflow section, creating a warm environment
around the whole oxygenator, or blowing off the condensate from the clogged fibres
by gas flushing. Further, it is noteworthy that the effect of water vapour conden-
sation is worse in ECLS procedures than in exhaled breath monitoring, due to the
presence of a continuous gas flow and higher flow rate at the oxygenator exhaust
port. Therefore, in the design of a capnometer for ECLS application, water vapour
condensation shall be considered and method to avoid it implemented since it can af-
fect the CO2 concentration measurement based on optical methods. Considerations
about the architecture to implement (main-stream or side-stream) are important
in designing a CO2 intended to be connected to the oxygenator exhaust connec-
tor. Main-stream architecture has the advantage that no sampling line is needed
and therefore, there is no risk of obstruction. Further, water vapour condensation
can be avoided heating the sensor [78], and it is not affected by changes in water
vapour pressure [49]. One of the main disadvantages is the difficulty of connecting
the cuvette of a main-stream capnometer to the standard size (diameter of 1/4” or
3/8”) exhaust connector of a membrane oxygenator. Therefore a method that allows
an easy connection to the oxygenator should be considered. In side-stream sensor
the water vapour can easily condensate in the tube used to bring the gas sample
to the measuring chamber, leading to clotting of the sample line and compromising
the correct measurement [71]. Further, the use of Side-stream CO2 sensor at the
oxygenator exhaust port has the drawback of the environmental air pulled to the
measuring chamber together with the exhaust gas, which leads to the incorrect es-
timation of CO2 removed from the patient [79]. This can happen especially if the
sampling flow rate of the side-stream sensor is equal or higher than the exhaust gas
flow rate. Considering that during the ECLS procedure, the sweep gas flow can be
changed often, the risk of acquiring environmental air, especially during pediatric
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procedures that involve lower sweep gas flow is high. Position of the sampling line
is important, most of MO has one ore more vent ports used for protection against
blockage of the exhaust gas line, that can lead to increased pressure, and transfer
of microemboli to the blood [80]. If the sampling line is placed too close to a vent
port, the sample can be diluted with environmental air. To improve side-stream
sensor accuracy during ECLS procedures, the sampling tube may be placed inside
the MO exhaust port. [81]. In this, way the gas sample is gathered directly from
the gas compartment of the MO, preventing its dilution with environmental air.
However, this solution brings to sterilization issues that are not compatible with
clinical routine in the intensive care unit (ICU). Therefore, in ECLS applications,
a Main-stream CO2 sensor seems more appropriate than a Side-stream sensor. In
order to allow measurement of VCO2 as reported in equation 1.2, a method to ac-
quire the gas flow applied to the oxygenator shall be implemented. Regarding time
resolution of the CO2 concentration measurement, differently from respiratory cap-
nometry in which high time resolution is necessary to obtain information on the
end-tidal CO2, respiratory rate and exhaled breath waveform, capnometry applied
to ECLS procedures does not require such highly time-resolved measurement, as in
ECLS applications the oxygenator exhaust gas flow and CO2 concentration change
slowly. Therefore, temporal resolution of the order of minutes is sufficient to extract
information about the ECLS procedure, since are used for evaluation of long-term
therapy progress and trends. Finally, a CO2 sensor for ECLS application should not
be designed as a standalone device, but rather it should be interfaced with monitor-





In this section, the development of the CO2 sensor is described. At first, the flow
measurement section’s development is disclosed, and then the sensor’s section for
carbon dioxide concentration monitoring is described. Temperature effect on opti-
cal elements performance is analyzed both theoretically and experimentally, and a
method for compensation of the temperature effect is proposed.
3.1 Gas Flow measuring section
As reported in Equation 1.2, to measure VCO2, information on gas flow is necessary.
Mass gas flow sensors represent the state of the art technology for gas flow measure-
ment. These sensors are based on the thermal measurement principle. Within the
sensors, MEMS-based calorimetric microsensors measure the changes in temperature
gradient caused by mass flow. Figure 3.1 shows the measuring principle exploited
by these sensors.
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Figure 3.1: Mass flow sensor measuring principle.
For the development of the gas measuring unit, we focused on two mass airflow
sensor: Sensirion SFM4100 and Posifa PMF4000. According to their datasheets,
both sensors have a measurement range of 0-20 SLM (Standard Liter per Minute)
and similar accuracy performance. Sensors performance has been tested comparing
their output to a reference flow sensor, at several flow rate values. From the experi-
mental evaluation, both sensors outputs are close to the flow rate measured with the
reference instrument, however, SFM4100 shows slightly better performance with an
average error of 0,12 SLM against the average error of 0,18 SLM of PFM4000. Con-
sidering the final application, the presence of water vapour within the gas exhaust
shall be taken into account. If the flow sensor is placed at the oxygenator exhaust
port of the MO, water vapour can easily condensate within the sensor leading to
incorrect flow rate measurement or sensor failure. Increment of the sensor temper-
ature to avoid the water vapour condensation is not a suitable solution, as it would
interfere with the measurement principle exploited by the flow sensor, that depends
on the cooling effect applied by a gas flow on a heating element placed within the
sensor [82]. Therefore, to avoid measurement error due to water vapour, the GF
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measurement section has been designed to be positioned at the inlet port of the
MO. Further, positioning of the flow sensor at the inlet gas line of the membrane
oxygenator provides the operator direct feedback about the sweep gas flow used for
the extra corporeal procedure and can be used to detect the disconnection of the
gas line. Considering the positioning at the inlet gas line of the MO, the SFM4100
has the advantage that its connector can be easily substituted and replaced with a
connector suitable for the inlet gas tube diameter. For these reasons, we opted for
the SFM4100 sensor. The flow sensor data are communicated through I2C interface
to the CPU contained in the CO2 measurement section. In Figure 3.2 is reported the
developed sensing platform, made up by two sections, one for measurement of gas
flow applied to the MO and one for CO2 concentration measurement in the exhaust
gas.
Figure 3.2: (a) Developed CO2 sensing platform. (1) Flow measurement section; (2)
CO2 measurement section. (b) Schematic representation of flow sensor and CO2 sensor on
MO.
3.2 CO2 measuring section
The CO2 measurement section has been entirely developed and is made up of three
subsections:
1. emission stage for the generation of the mid-IR beam;
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2. receiver stage for the detection, conditioning and amplification of the optical
signal after CO2 absorption and;
3. CPU for signal acquisition, processing, and communication with the flow sen-
sor section and a host device.
For both emission and detection of the mid-IR beam, optical elements of InAsS-
b/InAs (LED Microsensor NT, Saint-Petersburg, Russia) are used [83]. LED and
PD are placed on opposite sides of a measuring cuvette and are mechanically fixed
to assure the correct positioning and optimal optical coupling. In order to improve
optical coupling and obtain the best performance in terms of signal-to-noise ratio
(SNR), both LED and PD InAnSb/InAs chip are mounted on TO-18 package with
a parabolic reflector. The parabolic reflector allows a more directive optical beam to
be generated and detected, leading to a higher optical signal acquired by the sensor.
Figure 3.3 shows a comparison of beam divergence between optical element with
and without the parabolic reflector (data provided by the manufacturer).
Figure 3.3: Beam divergence comparison between optical element without and with
parabolic reflector.
In order to protect the optical elements, a sapphire glass window is mounted
on the parabolic reflector. In the following figure, the optical elements package is
shown.
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Figure 3.4: InAsSb/InAs optical element package with parabolic reflector.
As only a single LED-PD couple is used, this solution represents a single-channel
architecture. Use of the single-channel architecture allows obtaining a simpler de-
vice, easy to assemble and cheaper, as no optical filters or beam splitter are used.
Since each InAsSb/InAs elements is different in terms of emission efficiency and
photosensitivity, the CO2 sensor hardware has been designed to allow modulation
of LED current (through a PWM signal) and setting of receiver stage gain, by the
microcontroller unit. This flexibility allows the proper tuning of each optical couple
in order to achieve the best performance. As reported in section 2.3, main-stream
architecture is considered more suitable for ECLS application than side-stream.
Therefore, the CO2 sensor has been designed following this assumption, and the
measuring cuvette designed to be directly connected to the MO exhaust gas con-
nector. In order to prevent water vapour condensation, a heating system has been
implemented on both emitter and receiver stage. The Heating system is composed
of resistances mounted on the rear of the electronics boards that generate heat, an
aluminium ring that surrounds the optical elements and transfers the generated heat
along the measuring chamber, and a digital temperature sensor for the temperature
monitoring. CPU controls the emitter’s temperature and the receiver stages by
switching ON and OFF the current circulating in the resistances. A block diagram
of the proposed CO2 sensor architecture is reported in Figure 3.5, while in Figure
3.6 is reported the exploded drawing and a picture of the developed CO2 sensor.
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Figure 3.5: Schematic representation of the sensor: (1) CPU board; (2) aluminum rings;
(3) emitter board; (4) InAsSb/InAs element; (5) digital temperature sensor; (6) receiver
board; (7) heating resistances; (8) Flow sensor communication cable; (9) power supply/RS-
485 cable.
Figure 3.6: (a) Exploded drawing of the CO2 sensor: (1) CPU board; (2) aluminum
rings; (3) emitter board; (4) InAsSb/InAs element; (5) digital temperature sensor; (6)
receiver board; (7) heating resistances; (8) Flow sensor communication cable; (9) power
supply/RS-485 cable. (b) Assembly of the developed CO2 and plastic cuvette.
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Thanks to the implemented heating system, the water vapour condensation is
prevented not only on optical elements but also in their proximity, obtaining a
water-free cuvette. Figure 3.7 shows an example of water vapour condensation on
a cuvette placed at MO exhaust port that occurs without implementing a heating
system.
Figure 3.7: Effect of water vapour condensation on a test cuvette placed at the exhaust
port of a membrane oxygenator.
Further, without implementing the heating system, water vapour condensation
leads to total degradation of the optical signal, as confirmed experimentally record-
ing the optical signal from CO2 sensors without the implemented heating system
while relative humidity (RH%) of the gas flow increases. As RH% increases, water
vapour starts to condensate on the measuring cuvette walls and optical elements,
leading to signal degradation. With the heating system’s implementation, the opti-
cal signal is not affected by high humidity condition and water vapour condensation,
as confirmed experimentally. Figure 3.8 shows the experimental results, comparing
the effect of water vapour condensation on the optical signal with and without the
heating system’s presence.
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Figure 3.8: Sensor output voltage, without (blue line) and with (yellow line) implemen-
tation of the heating system, versus relative humidity (orange line).
The gas temperature at the exhaust port of a MO usually is 38 °C during ECLS
procedures such as CPB [84]; therefore, increasing the sensor’s temperature mea-
suring chamber to 40 °C prevents water vapour condensation. Even though the
sensor’s measuring chamber’s heating prevents water vapour condensation, an in-
crease in optical elements temperature brings side effects relevant to LED and PD
efficiency. Moreover, the implemented heating system’s goal is to prevent water
vapour condensation not only on optical elements but also on the entire measuring
chamber, preventing the formation of water drops that will move on the optical ele-
ments over time. For this reason, heating elements larger than the optical elements
package has been used. This solution allows a more efficient diffusion of heat along
the measuring chamber, preventing the formation of water drops. However, using
larger heating elements to improve the heat diffusion leads to larger oscillations in
temperature of emitter and receiver stages.
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3.3 Temperature Effect on InAsSb/InAs optical el-
ements
Since the temperature affects both InAsSb/InAs LED and PD performance, tem-
perature effect has been analyzed. In this section, both theoretical and experimental
analysis of temperature effect on LED and PD are presented. Further, methods to
compensate for the temperature effect are disclosed.
3.3.1 Analysis of Temperature Effect on Receiver Stage
The temperature increase of the receiver PD determines an increase of both dark
current noise and response time. Dark current noise arises from the generation of a
current on a photosensitive device even if photons are not detected. The movement
of charges that generates the dark current noise mainly depends on the device’s
thermal condition, and it increases as the temperature increases. This effect worsens
the SNR (signal-to-noise ratio) but can be compensated through post-processing on
the acquired signal. Slower PD response can be compensated using an appropriately
long duration for emission pulse, being sure that the pulse duration allows the PD
to reach the steady-state. In our system, the emission pulses are generated at 100
Hz frequency with a pulse duration of 1 ms. To evaluate if the temperature affects
the PD photosensitivity (i.e., the ability of the PD to generate current when hit by
photons), a theoretical approach has been used at first. The spectral response of an
InAsSb/InAs PD can be described by the sum of two Gaussian curves G1 and G2
[85]:
RPD(λ, T ) = R0 · [K1 ·G1(λmax(T ),∆λ(T )) +K2 ·G2(λmax(T )− λ0,∆λ0] (3.1)
where R0 is the PD integral photodiode sensitivity [A/W], ∆λ(T) is the FWHM,
λmax(T) is peak wavelength, K1, K2, λ0 and ∆λ0 are adjustable parameters, set in
order to fit the spectral response data provided by the manufacturer at T = 27 °C
(Figure 3.9). Within the temperature range 0 to 50 °C the following relationships
are valid, ∆λ(T) ∼ 0.1 λmax(T) and dλmax/dT = 4.5 nm/°C [85].
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Figure 3.9: Simulated PD spectral response (solid line) and data provided by the manu-
facturer (dots).
Solving Equation 3.1 for several temperature conditions highlights that tempera-
ture variations lead to the shift of the receiver spectrum peak wavelength. At higher
temperature, λmax moves to higher values and vice-versa. This effect in shown in
Figure 3.10, where detection spectra for several temperature values are reported.
From Equation 3.1 is also highlighted that increase on PD temperature only affect
photosensitivity in case of large temperature variations, and even in that case pho-
tosensitivity variations are small. Therefore the effect on photosensitivity around
40 °C, temperature range at which the heating system works, can be considered
negligible.
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Figure 3.10: Simulation of PD spectra at different temperatures.
3.3.2 Analysis of Temperature Effect on Emitter Stage
Emitted optical power generated by a InAsSb/InAS LED can be described by the
following equation:




∆λ(T )2 + (λ− λmax(T ))2
(3.2)
where P0 is the total output power [µW], λ is the wavelength [nm], ∆λ and
λmax are the FWHM (Full Width at Half Maximum) and peak wavelength of the
emission spectra, respectively. For λmax we considered the value provided by the
LED datasheet at 27 °C [83]. As for the PD theoretical description, within the
temperature range 0 to 50 °C the following relationships are valid, ∆λ(T) ∼ 0.1
λmax(T) and dλmax/dT = 4.5 nm/°C [85]. By solving Equation 3.2 is possible to
describe the mid-IR LED emission spectrum at different temperatures as reported
in Figure 3.11.
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Figure 3.11: Simulation of emission spectra at different temperatures.
As the temperature increases, the peak wavelength of the emission spectrum
shifts to higher wavelengths values and at the same time the optical power intensity
decreases, as reported in Figure 3.12 where the total output power of the LED
was calculated in the temperature range 0-50 °C, integrating the emission spectra








∆λ(T )2 + (λ− λmax(T ))2
dλ (3.3)




In order to validate the considerations highlighted through the theoretical analysis of
InAsSb/InAs temperature dependency, experimental analysis has been performed.
To experimentally evaluate the effect of temperature on the receiver element, the
sensor’s output signal has been recorded activating the heating system only on the
receiver stage to avoid interference due to temperature effect on the emitter element.
Therefore, the data collected during the experimental analysis are relevant to the
working temperature range of the heating system implemented in the sensor (42-44
°C). The theoretical formulation expressed by Equation 3.1 is confirmed experimen-
tally, as we did not observe any correlation between the receiver stage temperature
and the output sensor signal (R2 = 0,02). The experimental result is reported in
Figure 3.13. Therefore, the PD photosensitivity dependency on temperature is neg-
ligible in terms of optical signal variation and does not affect the developed sensor’s
measurement.
Figure 3.13: Experimental evaluation of correlation between emitted output power and
receiver stage temperature. Blue dots represent the sampled value of the output sensor
voltage at several temperatures of the receiver stage. Red line represents the linear regres-
sion of the data.
Similarly, the temperature effect on the emitter element has been experimentally
studied activating the heating system only on the emitter stage, acquiring the sensor
output signal at several temperature values of the emitter stage. The experimen-
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tal result, reported in Figure 3.14, shows a negative linear correlation with an R2
coefficient of 0.93.
Figure 3.14: Experimental evaluation of correlation between emitted output power and
emitter stage temperature. Blue dots represent the sampled value of the output sensor volt-
age at several temperatures of the emitter stage. Red line represents the linear regression
of the data.
However, even though Figures 3.12 and 3.14 both show a negative correlation
between emitted optical power and temperature, their slopes are different. In par-
ticular, from the theoretical analysis, the sensor signal variation due to the emitter
element’s temperature variation should be negligible, but this is not confirmed exper-
imentally. Reason for the discrepancy between theoretical and experimental result
is attributable to the fact that in theoretical evaluation only the contribution of the
LED, intended as a "stand-alone" object, is considered while in the experimental set-
up is also considered the contribution of the receiver element since the experiment is
based on the analysis of the sensor’s voltage output. Therefore, to mathematically
describe the effect of temperature variation on a single channel mid-IR sensor, both
Emitter and Receiver spectral characteristics shall be considered simultaneously.
Equation 3.4 describes the behaviour of a single channel InAsSb/InAs optopair [69],
as the one used in the developed sensor.
A(λ, T ) = PLED(λ, T ) ·RPD(λ, T ) (3.4)
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Equation 3.4 highlights that the sensor’s output depends on how well the emission
and detection spectra are spectrally matched. The More the two spectra overlap
each other, higher the sensor’s output is. If, due to temperature effect, one of
the two spectra peak wavelength shifts, sensor’s output would be affected. Solving
Equation 3.4 for the Emitter temperature range 42 to 43 °C and considering the PD
temperature at 27 °C, allows simulating the experimental set-up used for the analysis
of temperature effect on emitter element (Figure 3.14). The result reported in Figure
3.15 shows that an increase of 1 °C reduces the output of 1.5%, while experimentally
the increase of 1 °C reduces the output of 2%. Considering the approximation made
by the mathematical model, this result confirms that the theoretical formulation
correctly describes the behaviour observed experimentally.
Figure 3.15: Theoretical evaluation of correlation between sensor’s output and emitter
element temperature, using sensor optopair formulation.
From the experiment has been estimated that the sensor output signal decreases
of approximately 70 mV/°C. Considering that in our sensor, the output signal is
reduced by approximately 700 mV at the maximum measurable value of CO2 con-
centration, and considering the non-linearity of the sensor response described by 2.2,
the above mentioned signal-temperature variability can not be tolerated. Further,
a signal decrease due to LED temperature increase was noticed even if the heating
system was turned off due to the LED’s "self-heating" effect. The current circu-
lating in the LED is sufficient to increase the optical element’s temperature, thus
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affecting its emitted power as discussed before. Therefore, a strategy to avoid the
sensor signal variation due to the emitter stage’s temperature variation is necessary.
3.3.4 Temperature Compensation
The results of the theoretical and experimental analysis suggest that temperature
variations on the emitter stage represent the major contributor to output sensor
signal variation, whereas the temperature effect on the sensitivity of the receiver
can be considered negligible. Therefore, methods to compensate for the tempera-
ture variations on the emitter stage ware studied, in order to improve the output
signal stability. At first, based on the linear regression obtained experimentally and
reported in Figure 3.14, a compensation algorithm has been developed, as expressed
in Equation 3.5:
Signaladjusted = Signalfiltered + (Tref − Tfiltered) · r (3.5)
where Signaladjusted is the signal compensated for the temperature effect, Signalfiltered
is the output of the moving average filter applied to the acquired signal, Tref is a ref-
erence temperature (mean value of the emitter stage temperature at steady state),
Tfiltered is the output of the moving average filter applied to the temperature data.
Since the temperature sensor is not placed next to the optical element but is in
contact with the aluminium ring of the heating system, the temperature sensor’s
does not correctly describe the temperature dynamics of the optical elements. The
reason is the thermal inertia introduced by the aluminium element that brings a
delay in heat diffusion. Therefore, to correct the error in the acquisition of tem-
perature data due to the temperature sensor’s position, digital filtering has been
implemented on optical and temperature signal. Two moving average filters with
different windows width have been used to filter the acquired signal and the tem-
perature. Using the above-mentioned filters allows compensation for the delay of
the heat diffusion, and obtain temperature data that better describe the optical ele-
ment temperature changes. The compensation algorithm’s output has been further
filtered through a moving average filter to improve signal stability. The proposed
compensation algorithm allows the real-time correction of the signal acquired by the
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sensor. In order to check efficiency of the proposed solution, compensation algorithm
output has been compared to the optical signal filtered with a moving average filter,
with filtering width of 90 samples (to compensate the temperature variation period
of the sensor). The new solution based on the proposed compensation algorithm
gives a result similar to the one obtained with the moving average in terms of signal
stability (SD= + 6.29 mV vs SD= + 7.38 mV). Further, the compensation algo-
rithm allows a shorter response time, as reported in Figure 3.16 in which a signal
variation has been introduced applying a gas flow with CO2 concentration of 2,5%.
The increment of CO2 causes the signal to decrease from approx. 3650 mV (sig-
nal value with environmental CO2 concentration) to approx. 3200 mV. Further, as
shown by Figure 3.16, without any compensation, due to thermal effect, the optical
signal is characterized by high instability that reduces the accuracy of the sensor.
Without any compensation, when a gas with CO2 concentration of 2,5 % is applied
at the sensor inlet, sensor’s output is 2,5 % ± 1 %. With the proposed compensation
method when a gas with CO2 concentration of 2,5 % is applied at the sensor inlet,
the concentration measured by the sensor is 2,5 % ± 0,1 %.
Figure 3.16: Comparison between the output of the compensation algorithm (blue) and
the output of a moving average filter (dashed red). In yellow, the originally acquired output
signal.
However, even though the proposed compensation algorithm allows to obtain a
much stable output signal, the results in terms of sensor accuracy were not suffi-
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ciently good. In particular, repeatability of the measurements with the same sensor
was low, and the behaviour of different sensor was not the same. Reasons for that
has been attributed to a different temperature-emitted optical power dependency
for each InAsSb/InAs LED, and therefore a differentr coefficient. Another reason
for poor measurements repeatability can be found in different thermal conditions
between the calibration and use phases. This means that the temperature acquired
by the temperature sensor is not able to describe the optical element temperature
effectively, probably due to its positioning and the thermal inertia introduced by
the heating element. For these reasons, we decided to develop another method to
obtain a stable and repeatable optical signal.
3.3.5 Temperature Control Algorithm
The previous results have highlighted that in order to have a stable optical signal,
stable thermal conditions are necessary. Therefore, we developed a method that
consists of an algorithm for generating periodical and controlled temperature varia-
tions on the emitter stage and synchronising the optical signal acquisition at known
temperature conditions. In this way, the optical signal is always sampled at the
same thermal conditions, and the signal variations due to heating–cooling dynamics
are not taken into account. The developed algorithm is made of two phases:
• an initial phase performed at start-up, necessary to allow the sensor to reach
the steady-state temperature, and
• a phase in which the heating module is alternatively turned on and off by the
CPU.
The initial phase (FIND_T_REG state) is necessary to tune the control algorithm on
the room temperature and to assure repeatability of the generated temperature os-
cillations used in the second phase. During the second phase, the CPU generates
controlled temperature oscillations switching alternatively on and off the heating sys-
tem. The heating system is switched off when the emitter stage temperature reaches
a threshold value (HeaterRefT) based on the steady-state temperature. While the
heating system is turned off (ACQ_NO_HEATING state) the output signal is acquired
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and processed by the CPU through a moving average filter. This condition is main-
tained for a fixed duration of 45 s. Once the 45 s elapse the algorithm moves to
the WAIT_COOLING state in which the signal acquisition is stopped, and the sensor
output signal is no more updated. The heating system is maintained off during this
state until a threshold value is reached (HeaterRefT - HYST_TEMP_HEATER_OFF). Fur-
ther, in this state, the emitter LED is turned off to remove the LED self-heating
due to the electrical current circulating. Once reached the threshold value, the al-
gorithm moves to the HEATING_NO_ACQ state in which both the LED and heating
system are turned on again. The algorithm then continues cyclically. A schematic





























HeaterRefT = Max_temp_SensorEmitter - DELTA_REGIME_T;
Figure 3.17: State diagram of Temperature Control Algorithm.
Through the proposed algorithm, the sensor output signal is updated only at the
same thermal conditions; therefore, the output changes due to temperature variation
are avoided. Outputs of the implemented algorithm are reported in Figures 3.18 and
3.19, in which the emitter stage temperature trend over time and the sensor output
signal are shown respectively.
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Figure 3.18: Emitter Stage Temperature trend obtained through the temperature control
algorithm.
Figure 3.19: Original output signal (blue) and output signal (yellow) obtained through
the temperature control algorithm.
As shown in Figure 3.18, the emitter stage temperature reaches the same values
at each acquisition cycle (HEATING_NO_ACQ state). Therefore, as reported in 3.19,
the output signal obtained through averaging operation of the signal acquired during
the HEATING_NO_ACQ state is much more stable than the original signal. Without
the implementation of the proposed algorithm, temperature dynamic on the emitter
stage is characterized by oscillations without a defined period. Therefore, simple
filtering methods such as a moving average on the acquired signal result poorly




The developed sensor and the algorithm described in section 3.3.5 have been vali-
dated both in-vitro and in-vivo. In this chapter, the results of the tests performed
on the developed CO2 sensor are reported.
4.1 Sensor Validation in Experimental Laboratory
Setting
At first, the developed sensor has been tested in an experimental laboratory set-
ting. Before testing, the sensor was calibrated by using gas tanks containing gas
mixtures of air and CO2 with known concentrations. The measurement range for
CO2 concentration was 0–9%, as the developed sensor is intended to be used for
treating patients in hypercapnic conditions (i.e. PaCO2 higher than 50 mmHg [86],
corresponding to a CO2 concentration of approximately 6.5%). The gas was let flow
through the sensor, and the output signal was recorded through a PC connected to
the sensor via RS-485 communication line. The following CO2 concentrations were
used for the calibration procedure; 0%, 2.5%, 5%, 7.5%, and 9%. The collected data
were used to obtain a calibration curve through polynomial interpolation. Example
of a calibration curve is reported in Figure 4.1.
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Figure 4.1: Example of calibration curve. Dots represent the values used for polynomial
interpolation.
Values of the interpolation curve relevant to the measurement range with reso-
lution step of 0.1%, have been then stored in the sensor’s flash memory. Through
the calibration table stored in its flash memory, the sensor is then able to convert
the output signal in CO2 concentration value, as a percentage value. Calibration
process is intended as a "one-time" operation, considering also that at each use of
the sensor, a "Zero" value is acquired in absence of CO2, and used for offset correc-
tion. At this time no evidence that the sensor will need a periodic calibration have
been gathered. If periodic calibration will be necessary, this operation can be eas-
ily carried out, since the calibration data can be loaded on sensor’s flash memeory
through serial communication port, without invasive operations on sensor’s elec-
tronic or optical parts. The developed sensor’s accuracy was verified by comparing
its measurement with the ones obtained by a "gold standard" device (Medtronic Mi-
crocap Plus Capnograph). The two sensors’ accuracy was compared using a mixture
of air and CO2 at several concentrations. In order to control the CO2 concentration
of the gas mixture used for the test, it was analysed through a bench gas analyser
(Servomex MiniMP 5200). In Table 4.1 are reported the data gathered during the
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test execution.
Table 4.1: Comparison between measurements got by the developed sensor and a "gold
standard" device for several CO2 concentration values. Error is expressed as average value
and standard deviation (SD).
CO2 set-point [v/v %] Developed CO2 Sensor "Gold Standard" Sensor
1.60 % 1.60 % 1.40 %
2.20 % 2.00 % 1.90 %
3.60 % 3.50 % 3.40 %
3.90 % 4.00 % 4.00 %
5.40 % 5.50 % 5.30 %
6.10 % 5.80 % 6.20 %
6.60 % 6.50 % 6.70 %
7.40 % 7.50 % 7.50 %
Average Error ± SD [v/v %] 0.13 ± 0.09% 0.15 ± 0.07 %
From data reported in the table, the average absolute error obtained for the
newly developed sensor (0.13%) is similar to the one obtained by the reference
device (0.15%), that is already validated for clinical practice. Further, the developed
sensor’s accuracy level complies with requirements prescribed by ISO 80601-2-55 as
reported in Figure 4.2. These results demonstrate the efficiency of the temperature
control algorithm in terms of output signal stability, therefore the developed sensor’s
reliability.
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Figure 4.2: CO2 concentration measurement provided by the newly developed sensor
(blue diamonds) and by the "gold standard" device (orange crosses). Dashed lines represent
the ISO 80601-2-55 error limits.
Sensor accuracy has also been evaluated comparing the measurement of twelve
sensors at several CO2 concentration level. The acquired values are reported in the
following table.
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Table 4.2: Evaluation of developed sensor accuracy, comparing the output of twelve
sensors.
Sensor ID CO2=0% CO2=2,5% CO2=5% CO2=7,5% CO2=9%
1 0,0% 2,2% 4,6% 7,1% 8,3%
2 0,0% 2,3% 4,7% 6,7% 8,4%
3 0,0% 2,4% 5,0% 7,7% 8,8%
4 0,0% 2,4% 5,1% 7,5% 8,9%
5 0,0% 2,7% 5,2% 7,6% 9,0%
6 0,0% 2,4% 5,0% 7,7% 8,8%
7 0,0% 2,7% 4,9% 7,6% 8,8%
8 0,2% 2,6% 5,1% 7,9% 9,0%
9 0,0% 2,5% 5,0% 7,6% 9,0%
10 0,0% 2,4% 5,2% 7,5% 9,0%
11 0,0% 2,5% 5,5% 7,5% 9,0%
12 0,1% 2,7% 5,1% 7,3% 9,0%
Average ± SD [v/v %] 0,0 ± 0,0% 2,5 ± 0,2% 5 ± 0,2% 7,5 ± 0,3% 8,8 ± 0,2%
Converting the results reported in Table 4.2 in mmHg, the sensor accuracy is:
± 1,5mmHg in the range 0-38 mmhHg, ± 2,3 mmHg in the range 39-57 mmHg,
and ± 3 mmHg in the range 58-68 mmHg. Therefore, the developed CO2sensor’s
performance can be considered similar to the performance of the capnometers for
respiratory monitoring reported in section 2.3.
4.2 In-Vivo Sensor Validation
Since the project’s goal was to develop a CO2 sensor for ECLS applications with TRL
of 9, validation of the product in its intended operational environment was necessary.
For this reason, we tested the developed CO2 sensor through in-vivo experiment.
The developed CO2 sensor has been tested in an animal model and the acquired
data compared with the ones taken with Medtronic Microcap Plus Capnograph.
Data were collected during the execution of experiments described in [58], in which
62
five pigs with induced cardiogenic shock were undergoing ECMO procedure. This
experiment was conducted as part of a major study aimed at comparing the effects of
treatments alone with VA ECMO in addition to intra-aortic balloon pump (IABP)
in pigs in cardiogenic shock. Data were obtained on the five pigs, at five different
levels of blood flow/gas flow ratio (between 0.5-1.5). Three data acquisition were
made for each level of blood flow/gas flow ratio. Acquired data are reported in
Table 4.3 (only one data set for each level of blood flow/gas flow ratio is reported).
Measurements from the newly developed capnometer and the reference device were
taken at the MO exhaust port. Further, the GF measurement taken at the inlet port
of the MO through our flow sensor and the one provided by a reference device were
compared. Finally, VCO2 data obtained by CO2 measurement from our system were
evaluated against VCO2 calculated through data gathered by the reference device.
VCO2 values have been calculated using Equation 1.2. As during in-vivo tests the
CO2 concentration cannot be set arbitrarily, but instead depends on the effectiveness
of the ECMO procedures and on parameters such as sweep gas flow and blood flow,
to validate our sensor we focused on the error obtained comparing the measurements
from our sensor with the ones taken with the reference device, that is routinely used
in clinical practice. The reference device considered is a CO2 sensor intended for
respiratory monitoring, and it can perform the measurements only in "intermittent"
gas flow conditions like breathing. Therefore, during our experiments, the reference
device was manually connected/disconnected from the MO exhaust port.




































































































































































































































































































































































































































































































































































































































































































































































































As reported in Table 4.3, the difference for GF, CO2 and VCO2 between the
developed sensor and the reference instrument is minimal. Therefore, these results
show that the developed CO2 sensor represents a reliable solution in the clinical
environment. Further, a similar error has been obtained both in in-vitro and in-
vivo tests for CO2 concentration. This result is significant since the main difference
between the two set-ups consists of the presence of water vapour in the oxygenator
exhaust. Therefore, the heating system implemented in the CO2 sensor to avoid
water vapour condensation, and relevant algorithm for temperature control, are
valid solutions. This is true even in long-term measurements since, during the in-
vivo test, the sensor has been able to work for several days without showing any form
of signal degradation. The results obtained through the in-vivo test demonstrated
that the developed sensor is functional in its intended environment of use, therefore
reaching the TRL 9, achieving the project goal. Based on the results obtained both
laboratory and clinical environment, the developed sensor has obtained the CE
mark. To date, approximately 150 sensors have been produced and distributed and
are currently used in intensive care units connected to multi-parametric monitoring




ECLS procedures have become more and more important over the years, and their
use has increased in the recent period due to the Covid-19 pandemic. Therefore
methods to enhance both safety and effectiveness of the extra corporeal procedure
are needed. All ECLS procedures involve a membrane oxygenator that totally or
partially substitutes the patient’s lung functionality, allowing both blood oxygena-
tion and carbon dioxide removal. Measurement of CO2 concentration in the exhaust
gas of a membrane oxygenator allows monitoring both patient’s status during the
ECLS procedure and the state of the membrane oxygenator and its performance.
Therefore, oxygenator exhaust capnometry represents a useful tool that allows cor-
rect management of the ECLS procedure and improves its safety, assuring a better
patient outcome. In this thesis, the development of a sensor specifically designed to
measure carbon dioxide concentration in the exhaust gas of a membrane oxygenator
during extra corporeal procedures is presented. The PhD project’s goal is not only
the development of a sensor prototype but also the development of a sensor with
Technology Readiness Level of 9, meaning that the developed sensor shall also be
proven and validated in the operational environment. The developed sensor is made
up by two sections: one for measurement of the gas flow applied to a membrane
oxygenator, and the other for the measurement of carbon dioxide concentration in
the exhaust gas, which represents the CO2 removed from the patient’s blood. The
proposed CO2 sensor is designed as a Main Stream sensor with a single channel
optical architecture, avoiding the use of optical filters and therefore obtaining a sim-
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ple, cheap and easy to assemble the system. As a high amount of water vapour
characterizes the oxygenator exhaust gas, condensation at the exhaust connector is
easy to occur. Therefore, in order to avoid water vapour condensation within the
optical sensor, with consequent degradation of the optical signal, a heating module
is implemented in the CO2 measurement section. Even though the implemented
heating system prevents water vapour condensation, temperature variations affect
the optical elements’ performance. Temperature effect on the optical elements used
in the CO2 sensor was analyzed both theoretically and experimentally, highlight-
ing the strong correlation between emitter LED temperature and acquired optical
signal. Even though both theoretical and experimental results highlight a negative
correlation between emitted optical power and emitter stage temperature, the two
relationships are characterized by different slopes. This result can be explained,
considering that, in the experimental setup, the sensor photodiode contributes to
the variation of the sensor’s output. In contrast, this contribution is not taken
into account in the theoretical formulation, as the emitter element is considered a
"stand-alone" component. To correctly describe the experimental setup, the for-
mulation reported in Equation 3.4 has been used. This formulation considers both
the emitter and receiver contribute to the sensor output, thus describing the sensor
optopair. Using it to simulate the experimental setup, the obtained relationship
between sensor output and emitter temperature is close to the one obtained experi-
mentally. The mathematical model used was confirmed valid and useful to evaluate
the effect of temperature changes introduced by the implemented heating system
on the optical elements. Further, as reported in [85], the mathematical model can
also be used to evaluate sensor sensitivity. Therefore, the adopted mathematical
model represents the basis for further improvement of the developed device since it
allows the exploration of our sensor’s behaviour for different conditions of use, e.g.,
higher temperatures, different optical path length, and higher CO2 concentration.
In order to remove the signal–temperature dependency and therefore improve sensor
sensitivity, an algorithm for heating system control was implemented. The proposed
solution consists in the generation of controlled and repeatable temperature oscil-
lations and acquisition of the sensor’s output signal always at the same thermal
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conditions. Use of the proposed temperature control algorithm results in a stable
output signal since only samples acquired at the same thermal conditions are consid-
ered. The main drawback of the implemented solution is the low time resolution of
the measurement. Considering the duration of a thermal cycle, there is a 90 seconds
delay in the detection of a CO2 concentration variation. However, this delay does
not represent a major problem considering that the sensor is intended for long term
therapy that lasts for days or weeks, meaning that the data gathered through the
sensors are used to get long-term information about therapy progress and trends.
The developed sensor’s accuracy has been compared against a CO2 sensor used in
clinical practice both through laboratory test and in-vivo test. The results show
that the developed system allows reliable measurement of gas flow and carbon diox-
ide concentration, and therefore of carbon dioxide removal rate VCO2. Therefore,
the developed sensor has been validated in in its intended operational environment,
achieving a technology readiness level equal to 9. As far as the author knows, only
other two devices for measuring of CO2 concentration specifically designed for ECLS
application are available at the moment, the CO2 sensor of Spectrum M4 system
(Spectrum Medical Ltd.) and the Hemolung RAS ECCO2R device (A-Lung Tech-
nologies, Inc.). Unfortunately, from the available documentation no information
about their performances in terms of CO2 concentration accuracy was found, nor
was it possible to compare them with the developed sensor experimentally. Spec-
trum M4 system CO2 sensor is based on the same optical principle exploited by the
developed sensor, and it seems designed as a "Main Stream" sensors, suitable for
connection to the exhaust port of the membrane oxygenator. Anyway, in the avail-
able documentation, the adopted solution to address the water vapor condensation
problem is not described. Further, similar to the developed sensor also the Spectrum
M4 system is designed as a double section architecture, with a gas flow measurement
section intended to be placed upstream of the membrane oxygenator, and the CO2
sensor connected to the exhaust port. Finally, the Spectrum M4 system calculates
the PCO2 value of the blood leaving the oxygenator. This value is obtained through
a proprietary algorithm based on the value measured by the CO2 sensor and to the
measurement of the atmospheric pressure. Future improvement of the developed
68
sensor should involve the development of an algorithm for estimation of the PCO2
value from the CO2 concentration measured in the exhaust gas. The developed sen-
sor fulfils the requirements prescribed by ISO 80601-2-55 standard relevant to the
accuracy of carbon dioxide concentration measurements and has obtained the CE
mark. Approximately 150 sensors have been produced and distributed, and they
are currently used in intensive care units connected to multi-parametric monitoring
systems for ECMO procedures and to ECCO2R devices.
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